These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6743781)

  • 1. Comparative bioavailability of two oral formulations of flurazepam in human subjects.
    Cooper SF; Drolet D; Dugal R
    Biopharm Drug Dispos; 1984; 5(2):127-39. PubMed ID: 6743781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative biopharmaceutical performance of imipramine formulations in man.
    Gagnon MA; Dupuis C; Bertrand MJ; Elie R; Dugal R
    J Clin Pharmacol; 1980; 20(2-3):151-8. PubMed ID: 6892919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of buffering on oxyphenbutazone absorption kinetics and systemic availability.
    Dugal R; Dupuis C; Bertrand M; Gagnon MA
    Biopharm Drug Dispos; 1980; 1(6):307-21. PubMed ID: 7459426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary report on the blood levels of Flurazepam administered in two different pharmaceutical formulations].
    Ghirardi P; Marzo A; Parenti MA; Grosso F
    Boll Soc Ital Biol Sper; 1979 Jan; 55(2):167-70. PubMed ID: 17955644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics, brain uptake, and receptor binding characteristics of flurazepam and its metabolites.
    Miller LG; Greenblatt DJ; Abernethy DR; Friedman H; Luu MD; Paul SM; Shader RI
    Psychopharmacology (Berl); 1988; 94(3):386-91. PubMed ID: 2833762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cimetidine with oxazepam, lorazepam, and flurazepam.
    Greenblatt DJ; Abernethy DR; Koepke HH; Shader RI
    J Clin Pharmacol; 1984 Apr; 24(4):187-93. PubMed ID: 6144699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A fatal monointoxication by flurazepam (Dalmadorm). Problems of the toxicological interpretation (author's transl)].
    Aderjan R; Mattern R
    Arch Toxicol; 1979 Oct; 43(1):69-75. PubMed ID: 533364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study.
    Mitler MM; Seidel WF; van den Hoed J; Greenblatt DJ; Dement WC
    J Clin Psychopharmacol; 1984 Feb; 4(1):2-13. PubMed ID: 6141188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of estazolam, flurazepam, and placebo in outpatients with insomnia.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1986 Jul; 47(7):362-5. PubMed ID: 2873132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood level profile in man following chronic oral administration of flurazepam hydrochloride.
    Kaplan SA; de Silva JA; Jack ML; Alexander K; Strojny N; Weinfeld RE; Puglisi CV; Weissman L
    J Pharm Sci; 1973 Dec; 62(12):1932-5. PubMed ID: 4762160
    [No Abstract]   [Full Text] [Related]  

  • 11. Gas--liquid chromatographic determination of flurazepam and its major metabolites in plasma with electron-capture detection.
    Cooper SF; Drolet D
    J Chromatogr; 1982 Sep; 231(2):321-31. PubMed ID: 7130312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On determination and pharmacokinetics of flurazepam metabolites in human blood (author's transl)].
    Aderjan R; Fritz P; Mattern R
    Arzneimittelforschung; 1980; 30(11):1944-7. PubMed ID: 7193008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers.
    Poo JL; Galán JF; Rosete A; de Lago A; Oliva I; González-de la Parra M; Jiménez P; Burke-Fraga V; Namur S
    Clin Ther; 2008 Apr; 30(4):693-9. PubMed ID: 18498918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma versus bone marrow flurazepam concentration in rabbits.
    Winek CL; Pluskota M; Wahba WW
    Forensic Sci Int; 1982; 19(2):155-63. PubMed ID: 7068069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of flurazepam and its major metabolites N-1-hydroxyethyl- and N-1-desalkylflurazepam in plasma by capillary gas chromatography.
    Salama Z; Schraufstetter B; Jaeger H
    Arzneimittelforschung; 1988 Mar; 38(3):400-3. PubMed ID: 3382464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic properties of benzodiazepine hypnotics.
    Greenblatt DJ; Abernethy DR; Divoll M; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):129-32. PubMed ID: 6132931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic vs. gastrointestinal presystemic extraction of oral midazolam and flurazepam.
    Ochs HR; Greenblatt DJ; Eichelkraut W; Bakker C; Göbel R; Hahn N
    J Pharmacol Exp Ther; 1987 Dec; 243(3):852-6. PubMed ID: 3694534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flurazepam hydrochloride, a benzodiazepine hypnotic.
    Greenblatt DJ; Shader RI; Koch-Weser J
    Ann Intern Med; 1975 Aug; 83(2):237-41. PubMed ID: 238445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of flurazepam by the small intestine.
    Mahon WA; Inaba T; Stone RM
    Clin Pharmacol Ther; 1977 Aug; 22(2):228-33. PubMed ID: 18313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.